PerkinElmer's bead-based AlphaLISA ® immunoassays are designed for the detection of analytes in biological samples. These chemiluminescent, no-wash assays are ideally suited for miniaturization and ...
Immunoassays have been widely adopted for analysis and quantification of low concentration proteins. The immunoassay is selective and sensitive; however, its utility has been limited in ...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced two ready-to-use HTRF® and AlphaLISA® no-wash assay kits designed to ...
PerkinElmer’s HTRF and AlphaLISA assay kits are designed to detect and quantify CHO host cell protein impurities. PerkinElmer has released two ready-to-use no-wash assay kits in April 2022, the ...
PerkinElmer and BioLegend entered an agreement that allows BioLegend to offer immunoassay development and bioanalytical testing based on PerkinElmer’s AlphaLISA® assay technology. Homogenous ...
Will enable cancer researchers to accelerate identification and optimization of therapeutic leads by better decoding KRAS mutations present in 25% of tumors WALTHAM, Mass. — PerkinElmer, Inc., a ...
Findings shared on open data portal to help in global pursuit of drug repurposing candidates for COVID-19 The NCATS research project is focused on studying small molecule drug compounds that are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results